ly3437943 retatrutide triple agonist glp-1 gip glucagon (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results Retatrutide targets three receptors for
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4












/prd-cl/product-medias/8f447f01-b0ce-420c-9118-a623209db925/MK1Y4BURKV/MK1Y4BURKV-1/1753891353920-MK1Y4BURKV-1-5.png)










![Charmeleon (99/97) [EX: Dragon] Human Ninja](https://cdn.shopify.com/s/files/1/0266/3209/3801/products/73c3158d-939d-4e14-8d54-3cd89bc9aadf_72022908-8523-4c48-a82a-c8482f1c6fda.png?v=1696334292)